Clinical outcomes analysis shows utility of cannabis for migraine, suggesting further randomized trials are needed.
Findings indicate utility of CBMPs for migraine, but randomized controlled trials are required to establish causation.
No takes yet. Share an insight, caveat, or question.
Hooper et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: